Dogecoin Cash, Inc. Completes Corporate Name Change

Author: Evelyn Baker Updated: 04-29-2025 06:05 AM

Dogecoin Cash, Inc. Completes Name Change Process

Dogecoin Cash, Inc. (OTC: CBDS) has officially completed its name change, a significant step that is now visible across the U.S. stock market systems. This update comes after a notification from the Financial Industry Regulatory Authority (FINRA), marking a new era for the company.

Background of the Change

The journey began with the filing of a Certificate of Amendment to the Articles of Incorporation with the Nevada Secretary of State. This crucial step was executed on November 13, 2024, and the name change became market effective on April 25, 2025. It demonstrates the company's commitment to evolving and aligning its brand with its mission.

Regulatory Notifications

In line with regulatory requirements, Dogecoin Cash, Inc. also submitted a Current Report on Form 8-K to the Securities and Exchange Commission (SEC) upon the completion of the name change. This disclosure highlights the company’s transparency and adherence to regulations concerning its corporate identity.

What Stays the Same

Despite the significant branding change, the company assures its stakeholders that there is no modification to its trading symbol, which remains as CBDS. This consistency is vital for current and potential investors looking up stock performance and updates in the financial markets.

Commitment to Communication

Dogecoin Cash, Inc. is dedicated to keeping its shareholders informed through various public filings and official communication channels. This commitment ensures that all stakeholders are updated on the company’s progress and strategic decisions.

About Dogecoin Cash, Inc.

As a publicly traded entity, Dogecoin Cash, Inc. owns and operates PrestoDoctor, a leader in medical cannabis telemedicine. The company is not just focused on healthcare but is also a pioneer in cannabis innovation, holding the first patented cannabis strain known as Ecuadorian Sativa, or "CTA." Additionally, it has developed a patented cannabis lozenge targeted for hypertension treatment. The company is actively involved in product development, licensing, and leveraging blockchain technologies.

Innovative Approaches

Dogecoin Cash, Inc. is adeptly navigating through the worlds of cannabis and technology by employing decentralized finance (DeFi) solutions and blockchain innovations. This forward-thinking approach opens up new market opportunities and enhances their product line, ultimately fostering growth.

Frequently Asked Questions

Why did Dogecoin Cash, Inc. change its name?

The name change was part of the company's strategy to better align its branding with its operational focus and mission in the cannabis and blockchain sectors.

What is the current trading symbol for Dogecoin Cash, Inc.?

The trading symbol remains CBDS, ensuring continuity for current investors.

How does Dogecoin Cash, Inc. plan to grow?

The company is focusing on cannabis product development, exploring blockchain technology, and offering innovative telemedicine services.

Where can investors find updates about Dogecoin Cash, Inc.?

Investors can stay updated through public filings and official communications released by the company.

Is there any ongoing development in cannabis products?

Yes, Dogecoin Cash, Inc. is actively engaged in developing new cannabis products and enhancing existing offerings to meet market demands.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.